-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The Long and Short of It: Using the New Factor Products

Program: Education Program
Session: Challenges in Hemophilia Care
Sunday, December 6, 2015, 9:30 AM-11:00 AM
W307, Level 3 (Orange County Convention Center)
Monday, December 7, 2015, 10:30 AM-12:00 PM
W304EFGH, Level 3 (Orange County Convention Center)

Amy L. Dunn, MD

Ohio State University, Nationwide Children's Hospital, Columbus, OH

Disclosures: Dunn: Baxalta: Consultancy , Honoraria , Research Funding ; Bayer: Consultancy , Honoraria , Research Funding ; CSL Behring: Consultancy , Honoraria , Research Funding ; Biogen: Consultancy , Honoraria , Research Funding ; Pfizer: Consultancy , Honoraria ; NovoNordisk: Consultancy , Honoraria , Research Funding . Off Label Use: Recombinant Porcine FVIII-Obizur.

See more of: Challenges in Hemophilia Care
See more of: Education Program
Previous Presentation | Next Presentation >>